For over 30 years, YURiA-PHARM has been at the forefront of
pharmaceutical industry in Ukraine, developing and producing
therapeutics and medical devices. Since 2015, we’ve set our sights on
pioneering biopharmaceutical research and development through
creating an innovative YP Biotech R&D center.

At the forefront of this endeavor are cutting-edge technologies that
encompass every stage of the development cycle, from biomolecule
design to pilot production of therapeutic products. Our robust
platforms for synthetic biology, process development, and extensive
product characterization, enable us to work with precision and
efficacy on development of next generation therapies aimed to
tackle complex and hard-to-treat diseases.

We are committed to advancing recombinant proteins and nucleic
acid-based therapeutics with an aim to provide foundation for
groundbreaking medicines, addressing unmet medical needs and
enhancing patient outcomes.

Having created the most advanced multi-purpose infrastructure for
biomedical research in Ukraine, we aim to transform our corporate
R&D center into an R&D Hub. This ambitious initiative will not only
solidify our position in the field of biopharmaceutical development
but also open doors for collaboration with scientists worldwide.